Sterling Capital Management’s Dyne Therapeutics DYN Stock Holding History

Sterling Capital Management’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$59.9K	Buy	3,720 +1,760	+90%	+$40.4K	﹤0.01%	1680
2026 Q2	$43.5K	Sell	1,960 -1,321	-40%	-$24.6K	﹤0.01%	1621
2026 Q1	$59.5K	Sell	3,281 -1,885	-36%	-$32.5K	﹤0.01%	1573
2025 Q4	$101K	Sell	5,166 -45	-0.9%	-$852	﹤0.01%	1526
2025 Q3	$65.9K	Buy	5,211 +3,414	+190%	+$38.9K	﹤0.01%	1673
2025 Q2	$17.1K	Buy	1,797 +1,714	+2,065%	+$18.9K	﹤0.01%	1850
2025 Q1	$868	Hold	83	–	–	﹤0.01%	2858
2024 Q4	$1.96K	Hold	83	–	–	﹤0.01%	2793
2024 Q3	$2.98K	Buy	+83	New	+$3.3K	﹤0.01%	1997

Other funds holding DYN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Sterling Capital Management's DYN Position: Q3 2026 in Review

Sterling Capital Management increased its Dyne Therapeutics (DYN) stake by 90% in Q3 2026, buying an estimated $40.4K and bringing the position to 3,720 shares worth $59.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

Sterling Capital Management first reported a position in DYN in Q3 2024 and has held it in 9 quarters since. The position peaked at $101K in Q4 2025. 87 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

Sterling Capital Management held 3,720 shares of Dyne Therapeutics worth $59.9K as of Q3 2026.
Sterling Capital Management bought 1,760 Dyne Therapeutics shares in Q3 2026, an estimated $40.4K.
Dyne Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1680 holding.
Sterling Capital Management first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 9 quarters since.
Sterling Capital Management's Dyne Therapeutics position peaked at $101K in Q4 2025.
87 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.